Under construction – not a live service
Sign in
Enrolling by invitationNo phase

MRI-guided radiation treatment for unfavorable prostate cancer

Tests MRI-guided brachytherapy and SBRT radiation in men with prostate cancer.

Plain-language title generated from the registry record
Registry title: MRI-guided Locoregional SBRT Prostate Program

Key facts

Where
Pamplona, SpainSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT07132073, who can take part

Where in Spain

  • Clínica Universidad de Navarra Cancer CenterPamplona, SpainNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Clinica Universidad de Navarra, Universidad de Navarra
Trial code
NCT07132073
Record updated
29 April 2026
Original description
The implementation of Magnetic Resonance Image Guided Radiotherapy (MRgRT) into a Prostate Cancer Program will allow to reproduce the results obtained with state-of-the-art brachytherapy combined with EBRT with the added advantage of convenience.Read full original descriptionShow less

MR-guided Brachytherapy and SBRT for Unfavorable Prostate Cancer

The implementation of Magnetic Resonance Image Guided Radiotherapy (MRgRT) into a Prostate Cancer Program will allow to reproduce the results obtained with state-of-the-art brachytherapy combined with EBRT with the added advantage of convenience.

Inclusion: Patients with unfavorable intermediate, high and very high risk PCa as per the NCCN stratification criteria ; Suboptimal candidates for high-dose therapy such as elderly, frail patients or patients with large volume glands (i.e, >60cm3) or extensive TURP in the prior 6-12 months should be considered cautionary indications; Patients with low risk of nodal spread may be treated on a MRI-guided local SBRT program.

Exclusion: No prior radiation therapy to the target areas; Patient able to undergo a MRI exam.

ClinicalTrials.gov NCT07132073